Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Magna International (NYSE:MGA) Expands China Presence with New Wuhu eDrive Facility

Magna International Inc. (NYSE:MGA), a global mobility technology leader, is increasing its manufacturing presence in China with the launch of a new facility in the Jiujiang Economic Development Zone in Wuhu. The move supports the accelerating shift toward electrification in the world’s largest automotive …

Team Kalkine | 19 November 2025

Freeport-McMoRan (NYSE:FCX) Projects Higher Copper and Gold Output as Grasberg Recovers

Freeport-McMoRan Inc. (NYSE:FCX) announced plans to restore large-scale production at PT Freeport Indonesia’s Grasberg operations in Central Papua beginning in the second quarter of 2026. This move marks a major step in returning one of the world’s most important copper and gold mines to …

Team Kalkine | 19 November 2025

Rothschild Redb Adjusts View on Amazon.com (NASDAQ:AMZN) in Latest Rating

Rothschild Redb downgraded Amazon.com (NASDAQ:AMZN) to a hold rating. The previous stance was strong-buy. The update appeared in a report released on Tuesday. The change was also noted by Zacks.com.

Aditi Sarkar | 19 November 2025

CFM International (NYSE:GE): Riyadh Air Places Firm Order for 120 LEAP-1A Engines

CFM International, a joint venture betweenGE Aerospace (NYSE:GE) and Safran SA (EPA:SAF), has secured a significant new order from Riyadh Air, with the carrier finalizing a firm purchase of 120 LEAP-1A engines. These engines will power the 60 Airbus A321neo aircraft that Riyadh Air …

Team Kalkine | 19 November 2025

Intuit (NASDAQ:INTU) to Launch Personalized Finance Apps Inside ChatGPT Under Multi-Year Deal

Intuit Inc. (NASDAQ:INTU) has revealed a significant multi-year strategic partnership with OpenAI aimed at launching Intuit-powered finance apps directly inside ChatGPT. The announcement marks a key step in Intuit’s broader ambition to integrateartificial intelligenceinto personal and business finance decisions at scale.

Team Kalkine | 19 November 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Climbs 136% on Roche Phase 3 Trial Win

Olema Pharmaceuticals (NASDAQ:OLMA) gained significant market attention after Roche Holding AG (OTC:RHHBY) unveiled promising findings from its phase 3 lidERA trial evaluating giredestrant, an investigational oral selective estrogen receptor degrader, in patients with early-stage ER+/HER2- breast cancer. The large-scale study included more than 4,100 …

Team Kalkine | 19 November 2025

Kroger (NYSE:KR) Expands Delivery Partnerships to Drive ECommerce Growth

The Kroger Co. (NYSE:KR) has refreshed its eCommerce strategy with an ambition to elevate digital performance and customer engagement across its platforms. According to the company, updates to its eCommerce plan are expected to contribute approximately USD 400 million to eCommerceoperating profitin 2026.

Team Kalkine | 19 November 2025

Risk-Off Sentiment Deepens Ahead of Key Economic Data and Nvidia Earnings

Market Movers :On Monday, the top gainers were Alpha Technology Group Limited (+139.84%), followed by Safe & Green Holdings Corp. (+49.77%). On the contrary OneConstruction Group Limited (-57.59%), and Cycurion, Inc. (-28.64%) declined the most the same day.

Team Kalkine | 18 November 2025

GlobalFoundries (NASDAQ:GFS) Integrates AMF to Accelerate Optical Communication for AI Datacenters

GlobalFoundries (NASDAQ:GFS) announced itsacquisitionof Advanced Micro Foundry, a major milestone cementing GF’s global leadership in silicon photonics—a technology fundamental toAI-scale data movement. The acquisition integrates AMF’s manufacturing facilities, intellectual property, and specialized workforce into GF’s global operations, strengthening the company’s capacity to support next-generation …

Team Kalkine | 18 November 2025

Vanda Pharmaceuticals (Nasdaq:VNDA) Reports Key Study Success for Tradipitant in GLP-1 Therapy Support

Vanda Pharmaceuticals Inc. (Nasdaq:VNDA) announced encouraging topline results from its randomized, double-blind, placebo-controlled study evaluating tradipitant for preventing nausea and vomiting triggered by GLP-1 receptor agonist therapy. The study examined adults who were overweight or obese and had no prior GLP-1 agonist exposure.Participants were …

Team Kalkine | 18 November 2025